DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
Williams B, MacDonald TM, Morant SV. et al.
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.
Lancet 2015;
386: 2059-2068
We do not assume any responsibility for the contents of the web pages of other providers.